Technical Analysis for ELTP - Elite Pharma Inc

Grade Last Price % Change Price Change
grade B 0.058 -1.86% -0.0011
ELTP closed down 1.86 percent on Tuesday, August 20, 2019, on 63 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical ELTP trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
50 DMA Support Bullish -1.86%
Outside Day Range Expansion -1.86%
Wide Bands Range Expansion -1.86%
50 DMA Support Bullish 1.22%
Calm After Storm Range Contraction 1.22%

Older signals for ELTP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma and Valeant Pharmaceuticals International. Elite currently has eight commercial products being sold, additional approved products pending manufacturing site transfer and the NDA for SequestOx™, for which it received the CRL from the FDA. Elite’s lead pipeline products include abuse-deterrent opioids which utilize the Company’s patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.
Manufacturing RTT Euphoriants Pharmaceutical Drugs Psychoactive Drugs CNX Nifty Fda Chronic Pain Contract Manufacturing Morphinans Heroin Opioid Morphine Alkem Laboratories
Is ELTP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.111
52 Week Low 0.0333
Average Volume 946,812
200-Day Moving Average 0.079
50-Day Moving Average 0.0552
20-Day Moving Average 0.0524
10-Day Moving Average 0.056
Average True Range 0.0076
ADX 26.91
+DI 18.8555
-DI 15.2908
Chandelier Exit (Long, 3 ATRs ) 0.04720000000000001
Chandelier Exit (Short, 3 ATRs ) 0.0614
Upper Bollinger Band 0.064
Lower Bollinger Band 0.0408
Percent B (%b) 0.74
BandWidth 44.274809
MACD Line 0.0006
MACD Signal Line -0.0008
MACD Histogram 0.0013
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0655
Resistance 3 (R3) 0.0653 0.0627 0.0643
Resistance 2 (R2) 0.0627 0.0608 0.0628 0.0638
Resistance 1 (R1) 0.0603 0.0596 0.0590 0.0605 0.0634
Pivot Point 0.0577 0.0577 0.0570 0.0578 0.0577
Support 1 (S1) 0.0553 0.0558 0.0540 0.0555 0.0526
Support 2 (S2) 0.0527 0.0546 0.0528 0.0522
Support 3 (S3) 0.0503 0.0527 0.0518
Support 4 (S4) 0.0505